Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02602314
Title Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia (SUSTRENIM)
Acronym SUSTRENIM
Recruitment Unknown status
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | ITA


No variant requirements are available.